ReviewFrontiers in endocrinology2026
Ammonia signaling network: the intersection of tumor metabolism, epigenetics, and metastasis.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Ammonia onAntioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ammonia signaling network plays a central role in the tumor microenvironment. It has evolved from a traditional concept of metabolic waste into a critical signaling molecule that profoundly promotes the progression of malignant tumors by regulating metabolic remodeling, epigenetic modifications, and tumor metastasis. As research continues to deepen, scientists have gradually revealed the molecular mechanisms of the ammonia signaling network in tumorigenesis and evolution, although a comprehensive understanding remains to be achieved. This network not only regulates the metabolic state of tumor cells but also enhances their migratory capacity by orchestrating epigenetic changes, thereby driving tumor metastasis and immune evasion. This article aims to systematically elucidate the significance of the ammonia signaling network in tumor metabolic dysregulation and epigenetic remodeling, delve into its role in the process of tumor metastasis, and ultimately outline potential therapeutic strategies targeting this network. By linking metabolism, epigenetics, and immunology, the ammonia signaling network provides a unified paradigm for understanding tumor biology and offers new insights and directions for future research and clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.